A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma

OBJECT: Early-phase clinical studies of glioma vaccines have shown feasibility and encouraging preliminary clinical activity. A vaccine that targets tumor angiogenesis factors in glioma microenvironment has not been reported. Therefore, we performed a pilot study to evaluate the safety and immunogen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Shibao, Shunsuke, Ueda, Ryo, Saito, Katsuya, Kikuchi, Ryogo, Nagashima, Hideaki, Kojima, Atsuhiro, Kagami, Hiroshi, Pareira, Eriel Sandika, Sasaki, Hikaru, Noji, Shinobu, Kawakami, Yutaka, Yoshida, Kazunari, Toda, Masahiro
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5940381/
https://ncbi.nlm.nih.gov/pubmed/29765561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25131
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados